Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

Taipei Exchange - Delayed Quote TWD

Feedback Technology Corp. (8091.TWO)

Compare

133.50

0.00

(0.00%)

At close: 1:30:26 PM GMT+8

Stock market today: Dow, S&P 500, Nasdaq set to slide amid tariff turmoil, earnings misses

Investors continue to grapple with Trump's shifting tariff policy and worries about the economy.

Yahoo Finance 8 minutes ago

NQ=F

ES=F

YM=F
Abercrombie & Fitch stock hammered by tariff concerns — why more brutal warnings lurk

Consumers' shift in spending is causing investor fear.

Yahoo Finance 14 hours ago

NKE

ANF

M
Trump tariffs give struggling Target cover to make one big change, at the expense of investors

Goodbye to quarterly earnings guidance for Target.

Yahoo Finance 22 hours ago

BJ

COST

TGT
Stocks react to tariffs, Trump's comments, ADP data: 3 Things

US stock futures (ES=F, NQ=F, YM=F) hover just above the flatline Wednesday morning as markets digest commentary from the US Secretary of Commerce, Howard Lutnick. In his address to the joint Congress session Tuesday night, President Trump warned of "a little discomfort" ahead tied to his tariff policies and coming reciprocal tariffs. ADP reported that private payrolls for the month of February came out significantly below estimates, ahead of the latest US jobs report due out this Friday. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 22 hours ago

YM=F

NQ=F

ES=F
Q2 2025 Zscaler Inc Earnings Call

Q2 2025 Zscaler Inc Earnings Call

Thomson Reuters StreetEvents 2 minutes ago

ZS
Dow Jones Futures: Market Sell-Off Resumes; AI Chip Maker Marvell Dives, JD Jumps, Palantir Falls

Futures tumbled after markets rallied on a Trump tariffs delay. AI chip play Marvell dived on earnings. JD.com soared. Palantir fell.

Investor's Business Daily 7 minutes ago

JD

JDCMF

F
Kroger Reports Fourth Quarter and Full-Year 2024 Results Announces Guidance for 2025

The Kroger Co. (NYSE: KR) today reported its fourth quarter and fiscal year 2024 results, provided 2025 guidance and updated investors on how Kroger is positioned for long-term sustainable growth.

PR Newswire 11 minutes ago

KR
Macy's Q4 Revenue Lag And Annual Outlook Disappoints Investors, Stock Slides

Macy’s Inc (NYSE:M) shares are trading lower in premarket on Thursday after the fourth-quarter earnings. The company reported a fourth-quarter sales decline of 4.3% year-on-year to $7.768 billion, missing the analyst consensus of $7.867 billion. Comparable sales decreased 1.1% on an owned basis and up 0.2% on an owned-plus-licensed-plus-marketplace basis. The company’s go-forward business comparable sales were down 0.7% on an owned basis and up 0.6% on an owned-plus-licensed-plus-marketplace bas

Benzinga 14 minutes ago

M
Burlington shares surge premarket on fourth-quarter earnings beat

Investing.com - Shares in Burlington Stores (NYSE:BURL) rose by more than 13% in premarket U.S. trading on Thursday as better-than-anticipated fourth-quarter income at the retailer helped to offset concerns over an "uncertain" outlook for 2025.

Investing.com 18 minutes ago

BURL
Quantum Computing Stocks: Why David Vs. Goliath Battle Favors Tech Giants

Quantum computing stocks continue to struggle in 2025 amid announcements from tech giants. D-Wave earnings are due on March 13.

Investor's Business Daily 21 minutes ago

MSFT

RGTI

RGTIW
5 Things to Know Before the Stock Market Opens

News of the day for March 6, 2025

Investopedia 23 minutes ago

AVGO

COST

MRVL
Macy's (NYSE:M) Reports Q4 In Line With Expectations

Department store chain Macy’s (NYSE:M) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 4.4% year on year to $8.01 billion. On the other hand, the company’s full-year revenue guidance of $21.2 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $1.80 per share was 16.7% above analysts’ consensus estimates.

StockStory 32 minutes ago

M
Macy's slides on weak 2025 earnings forecast; Q4 profit tops estimates

Investing.com -- Macy's (NYSE:M) reported mixed results for its fourth quarter of fiscal 2024 and missed analyst expectations for annual earnings guidance, sending its shares about 1% lower in the Thursday premarket trade.

Investing.com 33 minutes ago

M
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases in Patients with Lung Cancer

HOUSTON, March 06, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company” or “Plus Therapeutics”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announces that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Rhenium (186Re) Obisbemeda for the treatment of leptomeningeal metastases (LM) in patients with lung cancer. “Receivi

GlobeNewswire 41 minutes ago

PSTV
JD.com Stock Jumps. China E-Commerce Giant Posts Best Sales Growth Since 2022.

JD stock gained on Q4 earnings beat, with the e-commerce company's fastest sales growth in nearly three years.

Investor's Business Daily 41 minutes ago

JD

JDCMF
BJ's Wholesale Club beats Q4 earnings estimates, shares edge higher

Investing.com -- BJ's Wholesale Club Holdings, Inc. reported better-than-expected fourth-quarter earnings on Thursday, with adjusted earnings per share (EPS) beating analyst estimates. The company's shares rose 1.9% in early trading following the announcement.

Investing.com 44 minutes ago

BJ
Marvell Crashes 15% After Weak Outlook Sparks Investor Fears

Marvell's Modest Q1 Outlook Wipes Out Billions in Market Value

GuruFocus.com 48 minutes ago

MRVL
Analysts overhaul Marvell stock price targets after Q4 earnings

Marvell shares, a star performer in 2024, have fallen more than 20% so far this year.

TheStreet 50 minutes ago

MRVL

AMZN
JD.com (JD) Stock Jumps 6%, Boosts Dividend by 32% in Stellar Q4

JD.com Stock Leaps 6% Ahead of Robust Year-End Earnings

GuruFocus.com 54 minutes ago

JD
Marvell Stock Drops 15% as the Artificial Intelligence (AI) Chipmaker's Guidance Disappoints Investors

Shares of Marvell Technology (NASDAQ: MRVL), which makes semiconductors for the data infrastructure market, dropped 14.9% in Wednesday's after-hours trading session following the company's release of its report for the fourth quarter of its fiscal year 2025 (ended Feb. 1). The quarter's revenue and earnings were essentially in line with Wall Street's estimates, as was first-quarter guidance for the top and bottom lines. The main reason for the stock's decline was likely investor disappointment about guidance.

Motley Fool 54 minutes ago

MRVL

Performance Overview

Return	8091.TWO	TSEC CAPITALIZATION WEIGHTED ST
YTD	+6.37%	-1.39%
1-Year	+14.15%	+16.49%
3-Year	+76.15%	+28.07%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Feedback Technology Corp. (8091.TWO)

Related News

Stock market today: Dow, S&P 500, Nasdaq set to slide amid tariff turmoil, earnings misses

Abercrombie & Fitch stock hammered by tariff concerns — why more brutal warnings lurk

Trump tariffs give struggling Target cover to make one big change, at the expense of investors

Stocks react to tariffs, Trump's comments, ADP data: 3 Things

Q2 2025 Zscaler Inc Earnings Call

Dow Jones Futures: Market Sell-Off Resumes; AI Chip Maker Marvell Dives, JD Jumps, Palantir Falls

Kroger Reports Fourth Quarter and Full-Year 2024 Results Announces Guidance for 2025

Macy's Q4 Revenue Lag And Annual Outlook Disappoints Investors, Stock Slides

Burlington shares surge premarket on fourth-quarter earnings beat

Quantum Computing Stocks: Why David Vs. Goliath Battle Favors Tech Giants

5 Things to Know Before the Stock Market Opens

Macy's (NYSE:M) Reports Q4 In Line With Expectations

Macy's slides on weak 2025 earnings forecast; Q4 profit tops estimates

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases in Patients with Lung Cancer

JD.com Stock Jumps. China E-Commerce Giant Posts Best Sales Growth Since 2022.

BJ's Wholesale Club beats Q4 earnings estimates, shares edge higher

Marvell Crashes 15% After Weak Outlook Sparks Investor Fears

Analysts overhaul Marvell stock price targets after Q4 earnings

JD.com (JD) Stock Jumps 6%, Boosts Dividend by 32% in Stellar Q4

Marvell Stock Drops 15% as the Artificial Intelligence (AI) Chipmaker's Guidance Disappoints Investors

Performance Overview